Computational model of chimeric antigen receptors explains site-specific phosphorylation kinetics

Chimeric antigen receptors (CARs) have recently been approved for the treatment of hematological malignancies, but our lack of understanding of the basic mechanisms that activate these proteins has made it difficult to optimize and control CAR-based therapies. In this study, we use phospho-proteomic mass spectrometry and mechanistic computational modeling to quantify the in vitro kinetics of individual tyrosine phosphorylation on a variety of CARs. We show that each of the ten tyrosine sites on the CD28-CD3{zeta} CAR is phosphorylated by LCK with distinct kinetics. The addition of CD28 at the N-terminal of CD3{zeta} increases the overall rate of CD3{zeta} phosphorylation. Our computational model identifies that LCK phosphorylates CD3{zeta} through a mechanism of competitive inhibition. This model agrees with previously published data in the literature and predicts that phosphatases in this system interact with CD3{zeta} through a similar mechanism of competitive inhibition. This quantitative modeling framework can be used to better understand CAR signaling and T cell activation.